Andrzéj Horban
- Infectious Diseases top 5%
- Virology top 2%
- Epidemiology
- Emergency Medicine top 5%
- Hepatology top 10%
- Co-authors
- Jens LundgrenChristiane MoecklinghoffJosé Ramón ArribasYvon van DelftAndrew HillNathan ClumeckMark NelsonJan Gerstoft
- Topics
- HIV/AIDS drug development and treatment (11 papers)HIV Research and Treatment (8 papers)HIV/AIDS Research and Interventions (8 papers)
- Partner nations
- United KingdomDenmarkSpain
In The Last Decade
Andrzéj Horban
16 papers receiving 488 citations
Peers
Comparison fields: 5 of 45
- Infectious Diseases 365
- Virology 286
- Epidemiology 171
- Emergency Medicine 106
- Hepatology 92
Countries citing papers authored by Andrzéj Horban
This map shows the geographic impact of Andrzéj Horban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrzéj Horban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrzéj Horban more than expected).
Fields of papers citing papers by Andrzéj Horban
This network shows the impact of papers produced by Andrzéj Horban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrzéj Horban. The network helps show where Andrzéj Horban may publish in the future.
Co-authorship network of co-authors of Andrzéj Horban
This figure shows the co-authorship network connecting the top 25 collaborators of Andrzéj Horban. A scholar is included among the top collaborators of Andrzéj Horban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrzéj Horban. Andrzéj Horban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 13 | |
| 4 | 28 | |
| 5 | 15 | |
| 6 | 35 | |
| 7 | 1 | |
| 8 | Efficacy and safety of tenofovir DF (DF) in chronic hepatitis B virus infected patients with documented lamivudine resistance (LAM-R) | 10 |
| 9 | DELTA HEPATITIS IN HIV-INFECTED INDIVIDUALS IN EUROPE | 2 |
| 10 | 69 | |
| 11 | 20 | |
| 12 | 140 | |
| 13 | 44 | |
| 14 | 10 | |
| 15 | 5 | |
| 16 | Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen. | 48 |
| 17 | Efficacy of atazanavir (ATV) based HAART in patients switched from a stable PI or boosted PI (PI/r) treatment. Planned week 24 analysis of a phase IIIb 48 week multicenter, open-label, randomized, prospective trial. The SWAN study | 2 |
| 18 | 59 |
About Andrzéj Horban
Andrzéj Horban is a scholar working on Virology, Infectious Diseases and General Social Sciences, having authored 18 papers that have together received 505 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (8 papers). The work is most often cited by research in Virology (286 citations), Infectious Diseases (365 citations) and Hepatology (92 citations). Andrzéj Horban has collaborated with scholars based in United Kingdom, Denmark and Spain. Frequent co-authors include Jens Lundgren, Christiane Moecklinghoff, José Ramón Arribas, Yvon van Delft, Andrew Hill, Nathan Clumeck, Mark Nelson, Jan Gerstoft, Thomas Stark and Federico Pulido. Their work appears in journals such as PLoS ONE, Hepatology and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.